Multiplexed Detection of Respiratory Virus RNA Using Optical pH Sensors and Injection Molded Centrifugal Microfluidics
Author:
Nagl Stefan1ORCID, Suarez Gianmarco2, Tang Yuki3, Bayer Steevanson2, Cheung Peter4ORCID
Affiliation:
1. The Hong Kong University of Science and Technology 2. Hong Kong University of Science and Technology 3. Quommni Techhnologies Ltd. 4. peter.cheung@live.ca
Abstract
Abstract
Infectious pathogens, such as the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), are a threat to global health and prosperity, with the coronavirus disease 2019 (COVID-19) pandemic causing deaths and negative economic impacts worldwide. Pathogens continuously mutate, evading vaccines and treatments; monitoring is therefore crucial to preventing future outbreaks. But there are still many shortcomings in available diagnostic technologies, and scalable and convenient point-of-care technologies are highly demanded. In this work, we demonstrate the application of injection molded centrifugal microfluidic chips with integrated optical pH sensors for multiplexed detection of SARS-CoV-2, influenza A, and influenza B RNA. The optical pH sensors generated sensitive fluorescent readouts from diagnostic reverse transcription loop-mediated isothermal amplification (RT-LAMP) reactions; limits of detection for influenzas A and B, and SARS-CoV-2 of 89, 245, and 38 RNA copies per reaction, respectively, were attained. Results were obtainable within 44 minutes for SARS-CoV-2 and influenza A, and 48 minutes for influenza B. We implemented a data processing strategy that allowed for reliable, quantitative thresholds for deciding reaction outcomes based on numerical derivatives of the fluorescence curves, enabling 100% specificity. This work demonstrates the utility of optical pH sensors and injection molded centrifugal microfluidics for multiplexed infectious disease diagnostics with point-of-care applications.
Publisher
Research Square Platform LLC
Reference94 articles.
1. 1. M. L. Barreto, M. G. Teixeira and E. H. Carmo, J. Epidemiol. Community Health, 2006, 60, 192–195. 2. 2. GBD 2019 Collaborators, Global Burden of Disease Study 2019 (GBD 2019) Data Resources, 2019. 3. 3. D. M. Morens, G. K. Folkers and A. S. Fauci, Nature, 2004, 430, 242–249. 4. 4. B. Aslam, W. Wang, M. I. Arshad, M. Khurshid, S. Muzammil, M. H. Rasool, M. A. Nisar, R. F. Alvi, M. A. Aslam and M. U. Qamar, Infect. Drug Resist., 2018, 11, 1645. 5. 5. J. R. Rohr, C. B. Barrett, D. J. Civitello, M. E. Craft, B. Delius, G. A. DeLeo, P. J. Hudson, N. Jouanard, K. H. Nguyen, R. S. Ostfeld, J. V. Remais, G. Riveau, S. H. Sokolow and D. Tilman, Nat. Sustain., 2019, 2, 445–456.
|
|